CDC faces leadership exodus amid policy disputes, raising concerns over scientific independence and outbreak readiness.
Major talcum powder verdicts are reshaping corporate liability, public health debates, and mass tort litigation nationwide.
A Single Shot to Shield Against Two Viruses: EMA Poised to Approve Moderna’s COVID-Flu Combo Vaccine
EMA backs Moderna’s dual COVID-19 and flu vaccine, mCombriax, paving the way for EU approval ahead of the 2026–2027 season.
Casey Means’ Surgeon General nomination sparks debate over vaccines, chronic disease policy, and the future of U.S. public health.
Severe heart attack deaths are rising among Americans under 55, especially women. Experts warn of shifting risks and ...
Novo Nordisk slashes U.S. prices for Ozempic and Wegovy by up to 50%, reshaping access to diabetes and weight-loss care.
Mexico’s escalating cartel violence leaves over 70 dead, disrupting daily life, tourism, and regional economic stability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results